IMVT

IMVT R&D to Revenue

0.00%Fiscal year

Period ending:

IMVT FY R&D/Revenue%
IMVT FY R&D/Revenue1.00%-1.00%
2018-03-312026-03-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

IMVT r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 9 observations from Mar 31, 2018 to Mar 31, 2026.

Immunovant Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%

Compare r&d to revenue

All IMVT financial metrics · IMVT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.